A citation-based method for searching scientific literature

G Geller, J R Botkin, M J Green, N Press, B B Biesecker, B Wilfond, G Grana, M B Daly, K Schneider, M J Kahn. JAMA 1997
Times Cited: 156







List of co-cited articles
697 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
599
23

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
W Burke, M Daly, J Garber, J Botkin, M J Kahn, P Lynch, A McTiernan, K Offit, J Perlman, G Petersen,[...]. JAMA 1997
695
23

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
18

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
16

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
16

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.
W Burke, G Petersen, P Lynch, J Botkin, M Daly, J Garber, M J Kahn, A McTiernan, K Offit, E Thomson,[...]. JAMA 1997
355
16

Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors.
W C McKinnon, B J Baty, R L Bennett, M Magee, W A Neufeld-Kaiser, K F Peters, J C Sawyer, K A Schneider. JAMA 1997
77
19


The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.
F M Giardiello, J D Brensinger, G M Petersen, M C Luce, L M Hylind, J A Bacon, S V Booker, R D Parker, S R Hamilton. N Engl J Med 1997
332
12

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
12

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
913
11

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
11

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
T S Frank, S A Manley, O I Olopade, S Cummings, J E Garber, B Bernhardt, K Antman, D Russo, M E Wood, L Mullineau,[...]. J Clin Oncol 1998
332
11

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
242
11


Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
270
11

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
D A Berry, G Parmigiani, J Sanchez, J Schildkraut, E Winer. J Natl Cancer Inst 1997
253
11

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
F J Couch, M L DeShano, M A Blackwood, K Calzone, J Stopfer, L Campeau, A Ganguly, T Rebbeck, B L Weber. N Engl J Med 1997
520
10


Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
9

Physicians' knowledge of genetics and genetic tests.
K J Hofman, E S Tambor, G A Chase, G Geller, R R Faden, N A Holtzman. Acad Med 1993
155
9

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
D Shattuck-Eidens, A Oliphant, M McClure, C McBride, J Gupte, T Rubano, D Pruss, S V Tavtigian, D H Teng, N Adey,[...]. JAMA 1997
287
8

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
S A Narod, J S Brunet, P Ghadirian, M Robson, K Heimdal, S L Neuhausen, D Stoppa-Lyonnet, C Lerman, B Pasini, P de los Rios,[...]. Lancet 2000
383
8





AGA technical review on hereditary colorectal cancer and genetic testing.
F M Giardiello, J D Brensinger, G M Petersen. Gastroenterology 2001
229
8

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.
M A Rodriguez-Bigas, C R Boland, S R Hamilton, D E Henson, J R Jass, P M Khan, H Lynch, M Perucho, T Smyrk, L Sobin,[...]. J Natl Cancer Inst 1997
784
8

The genetic attributable risk of breast and ovarian cancer.
E B Claus, J M Schildkraut, W D Thompson, N J Risch. Cancer 1996
506
7



Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
345
7

Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
128
7

Genetic testing for children and adolescents. Who decides?
D C Wertz, J H Fanos, P R Reilly. JAMA 1994
203
7

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
7

Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.
B B Biesecker, M Boehnke, K Calzone, D S Markel, J E Garber, F S Collins, B L Weber. JAMA 1993
249
7

Genetic discrimination and health insurance: an urgent need for reform.
K L Hudson, K H Rothenberg, L B Andrews, M J Kahn, F S Collins. Science 1995
169
7

The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
346
7

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).
H F Vasen, J P Mecklin, P M Khan, H T Lynch. Dis Colon Rectum 1991
7

Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
J T Wijnen, H F Vasen, P M Khan, A H Zwinderman, H van der Klift, A Mulder, C Tops, P Møller, R Fodde. N Engl J Med 1998
309
7

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
920
7

Population-based molecular detection of hereditary nonpolyposis colorectal cancer.
R Salovaara, A Loukola, P Kristo, H Kääriäinen, H Ahtola, M Eskelinen, N Härkönen, R Julkunen, E Kangas, S Ojala,[...]. J Clin Oncol 2000
392
7

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?
J Audrain, B Rimer, D Cella, J Garber, B N Peshkin, J Ellis, J Schildkraut, M Stefanek, V Vogel, C Lerman. J Clin Oncol 1998
67
8

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
544
6

Future directions in genetic counseling: practical and ethical considerations.
Barbara Bowles Biesecker. Kennedy Inst Ethics J 1998
40
15

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
183
6

Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
262
6



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.